viernes, 20 de junio de 2025

American Society of Clinical Oncology (ASCO) 2025 May 30 - June 03, 2025 | Chicago, Illinois and Virtual +++++

American Society of Clinical Oncology (ASCO) 2025 May 30 - June 03, 2025 | Chicago, Illinois and Virtual https://www.medscape.com/viewcollection/37796?ecd=WNL_onc_ASCO-SPON_250620_MSCPEDIT_etid7510524&uac=148436CN&impID=7510524 Hematologic Cancers OS Data From CARTITUDE-1: A Cure for Myeloma? https://www.medscape.com/viewarticle/q-does-long-term-os-data-cartitude-1-portend-cure-myeloma-2025a1000foh?ecd=WNL_onc_ASCO-SPON_250620_MSCPEDIT_etid7510524&uac=148436CN&impID=7510524 Q&A: New Myeloma Bispecific Rivals CAR T in Early Data https://www.medscape.com/viewarticle/q-new-myeloma-bispecific-rivals-car-t-early-data-2025a1000g9r?ecd=WNL_onc_ASCO-SPON_250620_MSCPEDIT_etid7510524&uac=148436CN&impID=7510524 Can New Combo Fill ‘Unmet Need’ in R/R Hodgkin Lymphoma? https://www.medscape.com/viewarticle/can-new-combo-fill-unmet-need-r-r-hodgkin-lymphoma-2025a1000fjc?ecd=WNL_onc_ASCO-SPON_250620_MSCPEDIT_etid7510524&uac=148436CN&impID=7510524 PVEK: A Game Changer in Rare, Deadly Blood Cancer? https://www.medscape.com/viewarticle/q-pvek-new-standard-care-rare-deadly-blood-cancer-2025a1000fog?ecd=WNL_onc_ASCO-SPON_250620_MSCPEDIT_etid7510524&uac=148436CN&impID=7510524

No hay comentarios:

Publicar un comentario